These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1436853)

  • 1. Meningococcal disease 1992.
    N Z Med J; 1992 Sep; 105(942):389. PubMed ID: 1436853
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of MeNZB vaccination in controlling the New Zealand meningococcal epidemic.
    Lennon D
    N Z Med J; 2008 Mar; 121(1270):110-2. PubMed ID: 18364765
    [No Abstract]   [Full Text] [Related]  

  • 3. Epidemic meningococcal disease in New Zealand: epidemiology and potential for prevention by vaccine.
    Bremner C; Lennon D; Martin D; Baker M; Rümke H
    N Z Med J; 1999 Jul; 112(1091):257-9. PubMed ID: 10448985
    [No Abstract]   [Full Text] [Related]  

  • 4. Meningococcal disease epidemiology and control in New Zealand.
    Wilson N; Baker M; Martin D; Lennon D; O'Hallahan J; Jones N; Wenger J; Mansoor O; Thomas M; Jefferies C
    N Z Med J; 1995 Oct; 108(1010):437-42. PubMed ID: 7478351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meningococcal B immunisation in New Zealand: why haven't we seen the data?
    Bolland M
    N Z Med J; 2008 Mar; 121(1270):107-9. PubMed ID: 18364764
    [No Abstract]   [Full Text] [Related]  

  • 6. Meningococcal vaccine.
    Tukuitonga C
    N Z Med J; 2001 Dec; 114(1145):557. PubMed ID: 11833953
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe outbreak of meningococcal disease in Auckland.
    Jackson G; Lennon D; Voss L; Flight R
    N Z Med J; 1987 Apr; 100(821):226. PubMed ID: 3455492
    [No Abstract]   [Full Text] [Related]  

  • 8. New Zealand's epidemic of meningococcal disease described using molecular analysis: implications for vaccine delivery.
    Dyet K; Devoy A; McDowell R; Martin D
    Vaccine; 2005 Mar; 23(17-18):2228-30. PubMed ID: 15755601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nursing innovation at the heart of immunisation campaign.
    Manchester A
    Nurs N Z; 2004 Sep; 10(8):10-1. PubMed ID: 15508963
    [No Abstract]   [Full Text] [Related]  

  • 10. Getting to grips with an epidemic.
    Desmond N
    Nurs N Z; 2004 Aug; 10(7):2. PubMed ID: 15460638
    [No Abstract]   [Full Text] [Related]  

  • 11. Infectious diseases--far from defeated.
    Chambers S; Baker M
    N Z Med J; 2004 Aug; 117(1200):U1013. PubMed ID: 15475983
    [No Abstract]   [Full Text] [Related]  

  • 12. Meningococcal disease in New Zealand today.
    Sewell F
    N Z Med J; 1987 Jul; 100(828):448-9. PubMed ID: 3451123
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful intervention in a group A meningococcal outbreak in Auckland, New Zealand.
    Lennon D; Gellin B; Hood D; Voss L; Heffernan H; Thakur S
    Pediatr Infect Dis J; 1992 Aug; 11(8):617-23. PubMed ID: 1523071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: "a prospective study of the effectiveness of the New Zealand meningococcal B vaccine".
    Lennon D; Stewart J; Crengle S
    Am J Epidemiol; 2008 May; 167(9):1140-1; author reply 1141-2. PubMed ID: 18359952
    [No Abstract]   [Full Text] [Related]  

  • 15. Meningococcal disease.
    Charlton R
    N Z Med J; 1999 Jun; 112(1090):241. PubMed ID: 10449004
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluating the post-licensure effectiveness of a group B meningococcal vaccine in New Zealand: a multi-faceted strategy.
    Ameratunga S; Macmillan A; Stewart J; Scott D; Mulholland K; Crengle S;
    Vaccine; 2005 Mar; 23(17-18):2231-4. PubMed ID: 15755602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive meningococcal disease in Northland, New Zealand.
    Mills C
    N Z Med J; 2011 Dec; 124(1347):95-7. PubMed ID: 22237578
    [No Abstract]   [Full Text] [Related]  

  • 18. The deathly progress of meningococcal disease.
    Prentice D; Hathaway M
    Nurs N Z; 2001 Jun; 7(5):18. PubMed ID: 12012896
    [No Abstract]   [Full Text] [Related]  

  • 19. The New Zealand Meningococcal Vaccine Strategy: a tailor-made vaccine to combat a devastating epidemic.
    Sexton K; Lennon D; Oster P; Crengle S; Martin D; Mulholland K; Percival T; Reid S; Stewart J; O'Hallahan J
    N Z Med J; 2004 Aug; 117(1200):U1015. PubMed ID: 15475985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The concept of "tailor-made", protein-based, outer membrane vesicle vaccines against meningococcal disease.
    Holst J; Feiring B; Naess LM; Norheim G; Kristiansen P; Høiby EA; Bryn K; Oster P; Costantino P; Taha MK; Alonso JM; Caugant DA; Wedege E; Aaberge IS; Rappuoli R; Rosenqvist E
    Vaccine; 2005 Mar; 23(17-18):2202-5. PubMed ID: 15755595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.